SCHEMBL20129518

SCHEMBL20129518

c1ccc(-c2ccc3c(c2)c2cc4c(cc2n3-c2ccc(-c3nc(-c5ccccc5)nc(-c5ccccc5)n3)cc2)sc2ccccc24)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 1/20 0.34
NR3C1 P04150 1/20 0.33
ATM Q13315 2/20 0.33
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GPR3 P46089 1/20 0.33
LIMK1 P53667 2/20 0.32
MAPT P10636 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RXRA P19793 1/20 0.32
PIK3CA P42336 1/20 0.32
PI4KA P42356 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
PTGER4 P35408 1/20 0.31
ROCK1 Q13464 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18505498 0.95 PIM3 (0.34) PIM3NR3C1ATMKDM4EL3MBTL1
SCHEMBL25133076 0.94 ATM (0.40) ATMKDM4EL3MBTL1GPR3MAPT
SCHEMBL18505399 0.94 ATM (0.40) ATMKDM4EL3MBTL1GPR3MAPT
SCHEMBL19626193 0.94 PIM3 (0.38) PIM3NR3C1ATMKDM4EL3MBTL1
SCHEMBL22257660 0.93 KDM4E (0.34) PIM3ATMKDM4EL3MBTL1GPR3
SCHEMBL25660307 0.93 MAPT (0.35) PIM3NR3C1ATMKDM4EL3MBTL1
SCHEMBL10014532 0.93 ATM (0.41) ATMKDM4EL3MBTL1GPR3MAPT
SCHEMBL15371803 0.93 PIM3 (0.36) PIM3NR3C1ATMKDM4EL3MBTL1
SCHEMBL18777275 0.93 GPR3 (0.38) PIM3NR3C1ATMKDM4EL3MBTL1
SCHEMBL22257658 0.92 KDM4E (0.33) PIM3ATMKDM4EL3MBTL1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10651396-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2020-05-12 US disclosed
US-20180130953-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-10 US disclosed
US-20180130953-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10651396-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same AOX1, OCIAD1, OCIAD2 PIM3 1612/4885NR3C1 2582/4885ATM 3082/4885
US-20180130953-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME AOX1, OCIAD1, OCIAD2 PIM3 1612/4885NR3C1 2582/4885ATM 3082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.